Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Chronic kidney disease and the involvement of estrogen hormones in its pathogenesis and progression.

Gluhovschi G, Gluhovschi A, Anastasiu D, Petrica L, Gluhovschi C, Velciov S.

Rom J Intern Med. 2012 Apr-Jun;50(2):135-44. Review.

PMID:
23326957
2.

Reproduction in women with end-stage renal disease and effect of kidney transplantation.

Ghazizadeh S, Lessan-Pezeshki M.

Iran J Kidney Dis. 2007 Jul;1(1):12-5. Review.

3.

Gender and the prevalence and progression of renal disease.

Neugarten J, Golestaneh L.

Adv Chronic Kidney Dis. 2013 Sep;20(5):390-5. doi: 10.1053/j.ackd.2013.05.004. Review.

PMID:
23978543
4.

Mutant FGF23 prevents the progression of chronic kidney disease but aggravates renal osteodystrophy in uremic rats.

Kusano K, Saito H, Segawa H, Fukushima N, Miyamoto K.

J Nutr Sci Vitaminol (Tokyo). 2009 Apr;55(2):99-105.

5.

Changes in fertility and hormone replacement therapy in kidney disease.

Holley JL, Schmidt RJ.

Adv Chronic Kidney Dis. 2013 May;20(3):240-5. doi: 10.1053/j.ackd.2013.01.003. Review.

PMID:
23928388
6.

Estrogens and progression of diabetic kidney damage.

Doublier S, Lupia E, Catanuto P, Elliot SJ.

Curr Diabetes Rev. 2011 Jan;7(1):28-34. Review.

PMID:
21067504
7.

[Osteoporosis, estrogens, and bone metabolism. Implications for chronic renal insufficiency].

Díaz López JB, Rodríguez Rodríguez A, Ramos B, Caramelo C, Rodríguez García M, Cannata Andía JB.

Nefrologia. 2003;23 Suppl 2:78-83. Review. Spanish.

8.

The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.

Chalmers L, Kaskel FJ, Bamgbola O.

Adv Chronic Kidney Dis. 2006 Oct;13(4):352-64. Review.

PMID:
17045221
9.

Effects of sex hormones on mesangial cells.

Neugarten J, Silbiger SR.

Am J Kidney Dis. 1995 Jul;26(1):147-51. Review.

PMID:
7611246
10.

[Differences between men and women with chronic kidney disease].

Suzuki H.

Nihon Rinsho. 2015 Apr;73(4):629-33. Japanese.

PMID:
25936152
11.

Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.

Mohsen A, Brown R, Hoefield R, Kalra PA, O'Donoghue D, Middleton R, New D.

J Nephrol. 2012 May-Jun;25(3):384-93. doi: 10.5301/jn.5000062.

PMID:
22241634
12.

Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.

Ambrus C, Molnar MZ, Czira ME, Rosivall L, Kiss I, Remport A, Szathmari M, Mucsi I.

Int Urol Nephrol. 2009 Dec;41(4):1029-38. doi: 10.1007/s11255-009-9631-0. Epub 2009 Aug 22.

PMID:
19701690
13.

AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury.

Machado FG, Poppi EP, Fanelli C, Malheiros DM, Zatz R, Fujihara CK.

Am J Physiol Renal Physiol. 2008 Jun;294(6):F1345-53. doi: 10.1152/ajprenal.00020.2008. Epub 2008 Apr 9.

14.

Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options.

Iglesias P, Carrero JJ, Díez JJ.

J Nephrol. 2012 Jan-Feb;25(1):31-42. doi: 10.5301/JN.2011.8481. Review.

PMID:
21748720
15.

Broken pump or leaky filter? Renal dysfunction in heart failure a contemporary review.

Petrie CJ, Mark PB, Weir RA.

Int J Cardiol. 2008 Aug 18;128(2):154-65. doi: 10.1016/j.ijcard.2007.12.016. Epub 2008 Jan 11. Review.

PMID:
18191240
16.

Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg?

Meuwese CL, Carrero JJ.

Arch Med Res. 2013 Nov;44(8):591-600. doi: 10.1016/j.arcmed.2013.10.009. Epub 2013 Nov 8. Review.

PMID:
24215784
17.

Effect of losartan on slowing progression of chronic allograft nephropathy.

Wang PX, Fan MQ, Huang CB, Feng JY, Xiao Y, Fang ZQ, Zhang YP.

Chin Med Sci J. 2005 Dec;20(4):231-6.

PMID:
16422249
18.
19.

Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.

Molony DA, Stephens BW.

Adv Chronic Kidney Dis. 2011 Mar;18(2):120-31. doi: 10.1053/j.ackd.2011.02.004. Review.

PMID:
21406297
20.

[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].

Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.

Presse Med. 2002 Nov 9;31(36):1714-20. Review. French.

PMID:
12467154
Items per page

Supplemental Content

Write to the Help Desk